Analysts Update Coverage on Canadian Stocks
Analyst Ratings (Canada) ARC Resources Ltd (ARX:CA) is rated Outperform by BMO Capital Markets, with its price target raised to $33.00 from…
Browse research
Analyst Ratings (Canada) ARC Resources Ltd (ARX:CA) is rated Outperform by BMO Capital Markets, with its price target raised to $33.00 from…
Analyst Ratings (USA) 4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital. Absci (ABSI) is…
Analyst Ratings (USA) Aardvark Therapeutics was rated Buy by HC Wainwright, with a target price of $40.00. AbbVie received a Buy rating…
Analyst Updates (Canada) Advantage Energy Ltd. (AAV:CA) had its price target raised to $12.00 by RBC Capital Markets, with the firm maintaining…
Canadian Stocks Adentra Inc. (ADEN:CA) was maintained at “Outperform” by National Bank, with its target price reduced from C$46 to C$41, suggesting…